Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer

Jeong, Dongjun; Kim, Hyeongjoo; Ban, Seona; Oh, Seunghyun; Ji, Sanghee; Kim, Doyeon; Ahn, Tae; Kim, Han; Bae, Sang; Kwon, Hyog; Im, Jungkyun; Lee, Moon; Cho, Hyun; Kim, Chang-Jin; Baek, Moo-Jun
December 2017
Journal of Cancer Research & Clinical Oncology;Dec2017, Vol. 143 Issue 12, p2493
Academic Journal
Purpose: Adjuvant chemotherapy (AC) is frequently considered in patients with high-risk stage II colorectal cancer (CRC). Among patients with stage II CRC who do not receive AC because they are not considered to be at high risk, 20-25% will develop recurrence and die from the disease. Elevated levels of KPNA2 have been observed in various cancers, and overexpression of KPNA2 is related to CRC progression. Methods: We examined the expression of KPNA2 using 293 CRC tissues, including 118 with stage II CRC, and investigated the applicability of KPNA2 as a biomarker to predict high-risk stage II CRC. Moreover, we further investigated the role of KPNA2 as an oncogene in CRC carcinogenesis using in vitro functional studies. Results: High KPNA2 expression was associated with vascular ( p = 0.027) and lymphatic invasion ( p = 0.009) in patients with stage II CRC. On multivariate analysis, high KPNA2 expression (HR 3.174, 95% CI 2.060-4.889; p < 0.001) was independently associated with survival in patients with CRC. The overall survival rate in patients with high KPNA2 expression was higher than that in patients with low KPNA2 expression in CRC ( p < 0.001), even in patients with stage II CRC ( p = 0.001). Additionally, KPNA2 was associated with tumorigenesis and cancer progression in CRC cells; high KPNA2 expression was associated with increased cell proliferation ( p < 0.05), migration ( p = 0.03), invasion ( p = 0.001), and semisolid agar colony formation ( p < 0.001). Conclusion: KPNA2 expression is useful for identification of patients with high-risk stage II CRC who could benefit from AC and that KPNA2 may also be a promising therapeutic target.


Related Articles

  • Association of the Actin-Binding Protein Transgelin with Lymph Node Metastasis in Human Colorectal Cancer. Ying Lin; Buckhaults, Phillip J.; Lee, Jeffrey R.; Hairong Xiong; Farrell, Christopher; Podolsky, Robert H.; Schade, Robert R.; Dynan, William S. // Neoplasia;Sep2009, Vol. 11 Issue 9, p864 

    Metastatic dissemination of primary tumors is responsible for 90% of colorectal cancer (CRC) deaths. The presence of positive lymph nodes, which separates stage I/II from stage III CRC, is a particularly key factor in patient management. Here, we describe results of a quantitative proteomic...

  • Predictive Factors for Lymph Node Metastasis in Signet Ring Cell Gastric Cancer and the Feasibility of Endoscopic Submucosal Dissection. Ji Yeon Kim; Yi Young Kim; Se Jin Kim; Jung Chul Park; Min Kyu Jung; Oh Kyoung Kwon; Ho Young Chung; Wansik Yu; Ji Young Park; Yong Kook Lee; Sung Sik Park; Seong Woo Jeon // Journal of Gastric Cancer;Jun2013, Vol. 13 Issue 2, p1 

    Purpose: Endoscopic submucosal dissection has recently been practiced on a differentiated type of early gastric cancer. However, there is no clear evidence for endoscopic treatments of signet ring cell carcinoma. The aim of this study is to identify the predictive clinicopathological factors for...

  • Detection of disseminated tumor cells in the lymph nodes of colorectal cancer patients using a real-time polymerase chain reaction assay. Lotspeich, Erkki; Schoene, Markus; Gerngroß, Heinz; Schmidt, Roland; Steinmann, Reinhard; Ramadani, Marco; Gansauge, Susanne // Langenbeck's Archives of Surgery;Oct2007, Vol. 392 Issue 5, p559 

    Postoperative treatment for colorectal cancer depends on tumor stage as defined by the International Union Against Cancer (UICC). Adjuvant chemotherapy is not recommended in patients without lymph node involvement (UICC stages I and II). As many as 20–30% of these patients, however, will...

  • Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy. Oltedal, Satu; Aasprong, Ole Gunnar; Møller, Jannicke H.; Kørner, Hartwig; Gilje, Bjørnar; Tjensvoll, Kjersti; Birkemeyer, Elke M.; Heikkilä, Reino; Smaaland, Rune; Nordgård, Oddmund // International Journal of Colorectal Disease;Oct2011, Vol. 26 Issue 10, p1271 

    Purpose: K-ras mutations predict resistance against epidermal growth factor receptor (EGFR)-directed therapy of metastatic colorectal cancer (CRC). The purpose of this study was to analyze the distribution of K-ras mutations in primary tumors and corresponding sentinel lymph nodes (SLNs) from...

  • Feasibility and response of helical tomotherapy in patients with metastatic colorectal cancer. Sun Hyun Bae; Seong Kwon Moon; Yong Ho Kim; Kwang Hwan Cho; Eung Jin Shin; Moon Sung Lee; Chang Beom Ryu; Bong Min Ko; Jina Yun // Radiation Oncology Journal;Dec2015, Vol. 33 Issue 4, p320 

    Purpose: To investigate the treatment outcome and the toxicity of helical tomotherapy (HT) in patients with metastatic colorectal cancer (mCRC). Materials and Methods: We retrospectively reviewed 18 patients with 31 lesions from mCRC treated with HT between 2009 and 2013. The liver (9 lesions)...

  • Expression of SDF-1α and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Yoshitake, N.; Fukui, H.; Yamagishi, H.; Sekikawa, A.; Fujii, S.; Tomita, S.; Ichikawa, K.; Imura, J.; Hiraishi, H.; Fujimori, T. // British Journal of Cancer;5/20/2008, Vol. 98 Issue 10, p1682 

    Although stromal cell-derived factor (SDF)-1α and its receptor CXCR4 are experimentally suggested to be involved in tumorigenicity, the clinicopathological significance of their expression in human disease is not fully understood. We examined SDF-1α and CXCR4 expression in colorectal...

  • Early colonic carcinoma with extensive lymph node metastases: case report and review of literature. Gi-Shih Lien; Chun-Nan Chen; Yeong-Shan Cheng; Sheng-Hsuan Chen; Shiann Pan; Mao-Chih Hsieh; Chia-Lang Fang; Itzkowitz, Steven // International Journal of Colorectal Disease;Jul2001, Vol. 16 Issue 4, p262 

    An 81-year-old woman had an early carcinoma invading focally into the upper submucosa of the middle-transverse colon, which was accompanied by extensive lymph node metastases and resulted in a poor prognosis. Although her tumor was small and flat, a rim of pale yellow-speckled mucosa adjacent to...

  • The Activity of RhoA is Correlated with Lymph Node Metastasis in Human Colorectal Cancer. Yoji Takami; Morihiro Higashi; Shinpei Kumagai; Paul Kuo; Hidetada Kawana; Keiji Koda; Masaru Miyazaki; Kenichi Harigaya // Digestive Diseases & Sciences;Feb2008, Vol. 53 Issue 2, p467 

    Abstract  Rho family GTPases play a pivotal role in the regulation of numerous cellular functions associated with malignant transformation and metastasis. To evaluate the role of these GTPases in colorectal cancer, the protein expression levels and activities of these proteins in...

  • Increased plasma MMP-2 protein expression in lymph node-positive patients with colorectal cancer. Langenskiöld, Marcus; Holmdahl, Lena; Falk, Peter; Ivarsson, Marie-Louise // International Journal of Colorectal Disease;May2005, Vol. 20 Issue 3, p245 

    Background: Degradation of the extracellular matrix plays an important part during the invasion of cancer cells into the surrounding tissue. The matrix metalloproteinases (MMPs) have a central role in this process as demonstrated in different malignancies. The aim of this study was to...

  • LINE-1 methylation shows little intra-patient heterogeneity in primary and synchronous metastatic colorectal cancer. Matsunoki, Aika; Kawakami, Kazuyuki; Kotake, Masanori; Kitamura, Hirotaka; Ooi, Akishi; Watanabe, Go; Minamoto, Toshinari; Kaneko, Mami // BMC Cancer;2012, Vol. 12 Issue 1, p574 

    Background: Long interspersed nucleotide element 1 (LINE-1) hypomethylation is suggested to play a role in the progression of colorectal cancer (CRC). To assess intra-patient heterogeneity of LINE-1 methylation in CRC and to understand its biological relevance in invasion and metastasis, we...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics